Federal Reserve Chair Kevin Warsh had an opportunity Thursday night to shape expectations heading into the central bank’s interest-rate-setting meeting in two week’s time — and in keeping with his practice of leaving markets guessing, he chose not to.
As more people switch to Coke, some analysts are getting more worried about the state of archrival Pepsi.
Popular AI names are under pressure again this week — but the pain could worsen after the Nov. 3 election.
Investors have a ‘love-hate relationship’ with tech stocks now — and experts recommend selectively hunting for bargains while also betting on the major cloud companies.
Here’s the Nov. 3 contest that “presents the biggest election-specific risk,” analysts say.
Shares of AbbVie, Eli Lilly and Gilead Sciences are trading at or near record highs.
Spending all your cash first can make your income surge in later years.
Elon Musk is set to reintroduce the Roadster sports car, possibly equipped with SpaceX thrusters.
It’s getting more expensive for investors to buy protection against a CoreWeave default.
The continued selloff in the AI trade is forcing investors to ditch highflying tech for relative safety of government bonds, even as hot inflation threatens to make that trade complicated.
The open-enrollment period goes from Oct. 15 to Dec. 7.
Reported details about Anthropic’s financial progress are adding to concerns about the health of the AI ecosystem.